Mitsuhiko Osaki Selected Research

Indicators and Reagents (Reagents)

4/2021

AMIGO2 as a novel indicator of liver metastasis in patients with colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitsuhiko Osaki Research Topics

Disease

45	Neoplasms (Cancer) 01/2023 - 06/2003
20	Carcinoma (Carcinomatosis) 01/2014 - 02/2002
15	Carcinogenesis 01/2023 - 05/2004
14	Neoplasm Metastasis (Metastasis) 01/2024 - 07/2005
6	Adenocarcinoma 01/2023 - 01/2003
6	Adenoma (Adenomas) 01/2023 - 01/2003
5	Stomach Neoplasms (Stomach Cancer) 01/2024 - 01/2007
5	Colorectal Neoplasms (Colorectal Cancer) 07/2023 - 02/2008
5	Inflammation (Inflammations) 02/2021 - 11/2013
5	Osteosarcoma (Osteogenic Sarcoma) 04/2019 - 03/2006
4	Renal Cell Carcinoma (Grawitz Tumor) 11/2020 - 01/2014
4	Squamous Cell Carcinoma of Head and Neck 07/2016 - 01/2007
4	Sarcoma (Soft Tissue Sarcoma) 09/2008 - 06/2003
3	Melanoma (Melanoma, Malignant) 12/2020 - 09/2005
3	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2009
3	Foreign Bodies (Foreign Body) 12/2015 - 11/2013
3	Glioma (Gliomas) 09/2012 - 05/2007
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2007 - 02/2002
3	Cardiomegaly (Heart Hypertrophy) 01/2003 - 05/2002
2	Adenomyosis 02/2024 - 11/2023
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2023 - 02/2010
2	Liver Diseases (Liver Disease) 01/2021 - 10/2008
2	Endometriosis 11/2018 - 01/2015
2	Colonic Neoplasms (Colon Cancer) 10/2018 - 05/2014
2	Rhabdomyosarcoma 06/2005 - 05/2002
2	Adenocarcinoma of Lung 04/2005 - 01/2004
2	Malignant Fibrous Histiocytoma 10/2004 - 11/2003
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2023
1	Graves Disease (Basedow Disease) 06/2023
1	Muscular Dystrophies (Muscular Dystrophy) 01/2023
1	Aneuploidy (Aneuploid) 03/2021
1	Obstructive Jaundice (Cholestatic Jaundice) 01/2021

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 03/2022 - 05/2002
8	MicroRNAs (MicroRNA)IBA 04/2019 - 01/2010
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 03/2003
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2014
4	Sirtuin 2IBA 09/2012 - 05/2007
4	Thymidine PhosphorylaseIBA 09/2005 - 03/2003
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2005 - 05/2004
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2004 - 11/2003
3	LigandsIBA 02/2024 - 02/2002
3	Messenger RNA (mRNA)IBA 11/2023 - 02/2015
3	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 07/2004
3	CytokinesIBA 11/2023 - 02/2005
3	HMGB1 Protein (HMG1)IBA 07/2023 - 01/2022
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2021 - 02/2005
3	Sunitinib (Sutent)FDA Link 11/2020 - 01/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 02/2008
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019 - 04/2011
3	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2018 - 01/2004
3	ProteomeIBA 07/2010 - 01/2007
3	Transcription Factor 3IBA 01/2008 - 04/2005
3	Core Binding Factor Alpha 3 SubunitIBA 01/2007 - 01/2005
3	Fas Ligand Protein (Fas Ligand)IBA 03/2005 - 02/2002
3	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 03/2005 - 11/2003
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2005 - 11/2003
3	Genetic Markers (Genetic Marker)IBA 01/2003 - 05/2002
2	ChemokinesIBA 02/2024 - 11/2023
2	Cadherins (E-Cadherin)IBA 11/2023 - 09/2007
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 11/2013
2	DystrophinIBA 01/2023 - 02/2010
2	Tyrosine Kinase InhibitorsIBA 11/2020 - 01/2018
2	EnzymesIBA 01/2019 - 04/2011
2	fascinIBA 10/2018 - 05/2014
2	Plasminogen Activator Inhibitor 1IBA 03/2018 - 01/2016
2	CaspasesIBA 05/2014 - 03/2006
2	Cysteine-Rich Protein 61IBA 07/2010 - 01/2007
2	Histones (Histone)IBA 04/2009 - 05/2007
2	TubulinIBA 04/2009 - 05/2007
2	ParaffinIBA 09/2008 - 06/2005
2	Transcription Factors (Transcription Factor)IBA 07/2005 - 04/2005
2	Estrogen ReceptorsIBA 07/2005 - 06/2003
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 05/2004 - 01/2003
2	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2004 - 01/2004
2	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 04/2004 - 01/2004
2	doxifluridineIBA 05/2003 - 03/2003
2	Proline (L-Proline)FDA Link 01/2003 - 05/2002
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2023
1	Long-Acting Thyroid Stimulator (LATS)IBA 06/2023
1	Immunoglobulin M (IgM)IBA 06/2023
1	Immunoglobulin G (IgG)IBA 06/2023
1	Cyclin D2IBA 01/2023
1	DNA Methyltransferase 3BIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 04/2021
1	Vitamin K 2 (Vitamin K2)IBA 01/2021
1	Vitamin K FDA Link 01/2021
1	Glutamic Acid (Glutamate)FDA Link 12/2020
1	AntiportersIBA 12/2020
1	Cystine (L-Cystine)IBA 12/2020

Therapy/Procedure

9	Therapeutics 01/2024 - 03/2006
3	Drug Therapy (Chemotherapy) 01/2024 - 06/2003
3	Intravenous Injections 01/2017 - 06/2011
2	Transplantation 01/2019 - 01/2009
1	Trachelectomy 07/2023
1	Hysterectomy 07/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2021
1	Blood Component Removal (Apheresis) 02/2021
1	Ligation 01/2021